Sarah Sammons, newly appointed Co-Leader of Breast Oncology at UMGCCC and former Senior Physician at Dana-Farber, shared a post on X:
”ALND indications in 2026 per Boughey at ASCO26
- IBC
- 3+ positive SLNs
- cN2a/cN3 upfront and after NAC, persistent nodal disease or matted nodes at presentation.
- SLN+ (ypN+) still pending A11202 and TAXIS.”
Other Articles about ASCO On OncoDaily.